239 related articles for article (PubMed ID: 16505409)
1. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
3. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
[No Abstract] [Full Text] [Related]
4. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
5. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
[TBL] [Abstract][Full Text] [Related]
6. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
[TBL] [Abstract][Full Text] [Related]
7. Treatment for hot flushes in women receiving tamoxifen.
Bydder SA; Spry NA
Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
[No Abstract] [Full Text] [Related]
8. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
11. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine hydrochloride for the treatment of hot flashes.
Schober CE; Ansani NT
Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
Barton D; La Vasseur B; Loprinzi C; Novotny P; Wilwerding MB; Sloan J
Oncol Nurs Forum; 2002; 29(1):33-40. PubMed ID: 11817491
[TBL] [Abstract][Full Text] [Related]
15. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Ensrud KE; Guthrie KA; Hohensee C; Caan B; Carpenter JS; Freeman EW; LaCroix AZ; Landis CA; Manson J; Newton KM; Otte J; Reed SD; Shifren JL; Sternfeld B; Woods NF; Joffe H
Sleep; 2015 Jan; 38(1):97-108. PubMed ID: 25325454
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
[TBL] [Abstract][Full Text] [Related]
17. Flushing in a menopausal woman taking venlafaxine.
Grady-Weliky TA; Hartmann DM
Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
[No Abstract] [Full Text] [Related]
18. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
19. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
[TBL] [Abstract][Full Text] [Related]
20. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
Barton DL; LaVasseur BI; Sloan JA; Stawis AN; Flynn KA; Dyar M; Johnson DB; Atherton PJ; Diekmann B; Loprinzi CL
J Clin Oncol; 2010 Jul; 28(20):3278-83. PubMed ID: 20498389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]